Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Renal Angiomyolipomas in TSC and Sporadic LAM
NCT00490789Phase 2Unknown
- Sponsor
- Cardiff University
- Start
- Oct 2005
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in tuberous sclerosis complex (TSC), lymphangioleiomyomatosis (LAM), sponsored by Cardiff University. Status: unknown.
02
Drugs
sirolimus
03
Conditions
tuberous sclerosis complex (TSC)lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on NCT00490789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00490789.